|
|
12277 134th Court NE, Suite 110
Redmond, WA 98052 USA
phone:425-825-0240
fax:425-825-7470
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.koronispharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Selective Viral Mutagenesis technology development for drugs to treat HIV and HCV. |
|
| Management |
| Donald J. Elmer, Interim CEO and Chairman of the Board; John Reno, Ph.D., Chief Operating Officer; Jeff Parkins, Vice President Clinical Development; Mark G. Fromhold, Ph.D., Director of Manufacturing;
Kevin S. Harris, Ph.D., Senior Virologist |
| |
|
|
| |
|
| Keywords |
| HIV, HCV, viral, mutagenesis, rna, clinical trials, HIVAIDS |
|
|
|
| Description |
|
Koronis develops Selective Viral Mutagenesis (SVM) technology to discover drugs against RNA viruses such as HIV and HCV through proof-of-concept clinical trials. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members